MYCOGEN HIRES PRESIDENT TO HEAD NEW SUBSIDIARY FOCUSING ON ANIMAL AND HUMAN HEALTH MARKETS
MYCOGEN HIRES PRESIDENT TO HEAD NEW SUBSIDIARY
FOCUSING ON ANIMAL AND HUMAN HEALTH MARKETS
SAN DIEGO, June 18 /PRNewswire/ -- Mycogen Corp. (NASDAQ: MYCO), a leader in the development of environmentally compatible biological pest control for agricultural crops, has appointed Charles J. Dumbrell to head up a newly formed subsidiary that will apply Mycogen's core technology to products to control pests that threaten human and animal health.
The new company, Parasitix Corp., will have access to Mycogen's extensive patent estate, which includes rights to a broad range of pesticidal toxins derived from the Bacillus thuringiensis (Bt) bacterium, as well as pesticidal agents based on fatty acids.
Dumbrell, who has more than 25 years of extensive experience in manufacturing, marketing, sales and management of global businesses in the chemical, pharmaceutical and agricultural industries, has been appointed president of Parasitix. Most recently, he was with American Cyanamid Co.'s chemical group with responsibility for new projects, business restructuring and divestiture management.
"We are pleased to welcome Chuck Dumbrell aboard to explore the vast collaborative opportunities available to us in the areas of human and animal health," said Jerry Caulder, Mycogen's chairman, president and chief executive officer. "His extensive background in all facets of running an international organization will be extremely useful in getting this new subsidiary up and operating."
"Our research has confirmed that Bts are effective against certain pests affecting animals and human, as well as many household pests. Parasitix's primary focus will be to target this tremendous opportunity," Caulder noted.
The cover story of the March issue of BioTechnology, reported that Mycogen had isolated Bt toxins active against such non-insect organisms as protozoan pathogens, mites and liver flukes, and had found new activity against adult houseflies. Mycogen holds 22 of the 39 U.S. patents issued for new Bt strains over the past four years.
Mycogen provides crop protection products and services. The company develops, manufactures and markets environmentally compatible products based on naturally occurring agents to control insects, parasites, weeds and other pests. Mycogen develops its products through the application of genetic engineering techniques and innovative formulations.
/CONTACT: Charles J. Dumbrell, president of Parasitix, or Marie C.Burke (investors) of Mycogen, 619-453-8030/
(MYCO) CO: Mycogen Corp.; Parasitix Corp. ST: California IN: CHM MTC SU: PER JL -- SD003 -- 1354 06/18/92 08:33 EDT